BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25978359)

  • 1. The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs).
    Vadasz Z; Rainis T; Nakhleh A; Haj T; Bejar J; Halasz K; Toubi E
    PLoS One; 2015; 10(5):e0125860. PubMed ID: 25978359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
    Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
    Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis.
    Eiza N; Garty M; Staun-Ram E; Miller A; Vadasz Z
    Clin Immunol; 2022 May; 238():109017. PubMed ID: 35460904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease.
    Fonseca-Camarillo G; Furuzawa-Carballeda J; Yamamoto-Furusho JK
    Cytokine; 2015 Oct; 75(2):389-402. PubMed ID: 26141420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
    Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
    Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
    Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
    D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
    J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
    Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the type and severity of inflammatory bowel disease in relation to IgG4 immunohistochemical staining.
    Şimşek HD; Basyigit S; Aktas B; Vargol E; Şimşek GG; Küçükazman M; Nazlıgül Y
    Acta Gastroenterol Belg; 2016; 79(2):216-21. PubMed ID: 27382941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.
    Sturm A; Leite AZ; Danese S; Krivacic KA; West GA; Mohr S; Jacobberger JW; Fiocchi C
    Gut; 2004 Nov; 53(11):1624-31. PubMed ID: 15479683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients.
    Brandhorst G; Petrova DT; Weigand S; Eberle C; von Ahsen N; Schmitz J; Schultze FC; Raddatz D; Karaus M; Oellerich M; Walson PD
    World J Gastroenterol; 2015 Mar; 21(11):3325-9. PubMed ID: 25805940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
    Hansen LK
    Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
    Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
    World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
    Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
    J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.